ELISA screen of novel compounds that inhibit S100P and RAGE binding to identify new candidate drugs as a new therapy for pancreatic cancer

Deborah Ogbeni, Rama Camara, David Chau, Stuart Kirton, Sharon Rossiter, Louise MacKenzie

    Research output: Contribution to conference › Abstract › peer-review

    Fingerprint

    Dive into the research topics of 'ELISA screen of novel compounds that inhibit S100P and RAGE binding to identify new candidate drugs as a new therapy for pancreatic cancer'. Together they form a unique fingerprint.

    Medicine & Life Sciences